Athersys Inc. plans to raise $20 million in public offering

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell.

Biotechnology company Athersys Inc. (Nasdaq: ATHX) of Cleveland announced it plans to sell more than 19.8 million common shares for $1.01 per share.

The company expects to collect $20 million in gross proceeds from the public offering, which is set to close by Wednesday, Feb. 1. The company’s stock at 2:10 p.m. on Monday, Jan. 30, was trading at $1.15 per share.

Click here to read the complete article.

Originally published January 30, 2017.